Chronic Lymphocytic Leukemia: An Update on Biology and Treatment-Reference-Cited by-同舟云学术

Chronic Lymphocytic Leukemia: An Update on Biology and Treatment

Published:2011-07-20 Issue:5 Volume:13 Page:379-385
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Riches John C.,Ramsay Alan G.,Gribben John G.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-011-0188-6.pdf

Reference50 articles.

1. •• Hallek M, Fischer K, Fingerle-Rowson G, et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet. 2010;376:1164–74. This phase 3 trial demonstrates the survival advantage of the addition of rituximab to fludarabine and cyclophosphamide, and underpins the current standard of care in CLL.

2. Eichhorst BF, Busch R, Stilgenbauer S, et al. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood. 2009;114:3382–91.

3. National Cancer Institute: Surveillance Epidemiology and End Results, SEER Stat Fact Sheets: Chronic Lymphocytic Leukemia. Available at http://seer.cancer.gov/statfacts/html/clyl.html . Accessed March 2011.

4. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–54.

5. Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101:4944–51.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZAP-70 expression is associated with increased CD4 central memory T cells in chronic lymphocytic leukemia: cross-sectional study;Hematology, Transfusion and Cell Therapy;2018-10

2. An update on current and prospective immunotherapies for chronic lymphocytic leukemia;Immunotherapy;2015-04

3. Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin;Leukemia & Lymphoma;2014-08-04

4. How to determine post-FCR therapy for cytogenetic risk-tailored elderly patients with chronic lymphocytic leukemia, maintenance rituximab or observation;Medical Oncology;2014-07-02

5. Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia;Revista Brasileira de Hematologia e Hemoterapia;2014-01